Counterfeit medicines continue to pose a significant risk to patient safety and the integrity of India’s pharmaceutical supply chain. According to the CRISILASPA State of Counterfeiting in India 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results